Match!
Louiza Kalokairinou
Katholieke Universiteit Leuven
15Publications
6H-index
58Citations
Publications 15
Newest
#1Louiza Kalokairinou (Katholieke Universiteit Leuven)H-Index: 6
#2Pascal Borry (Katholieke Universiteit Leuven)H-Index: 34
Last.Heidi Carmen Howard (Uppsala University)H-Index: 23
view all 3 authors...
Source
#1Louiza Kalokairinou (Katholieke Universiteit Leuven)H-Index: 6
#2Heidi Carmen Howard (Uppsala University)H-Index: 23
Last.Pascal Borry (Katholieke Universiteit Leuven)H-Index: 34
view all 25 authors...
Despite the increasing availability of direct-to-consumer (DTC) genetic testing, it is currently unclear how such services are regulated in Europe, due to the lack of EU or national legislation specifically addressing this issue. In this article, we provide an overview of laws that could potentially impact the regulation of DTC genetic testing in 26 European countries, namely Austria, Belgium, Cyprus, the Czech Republic, Denmark, Estonia, Finland, France, Germany, Greece, Hungary, Ireland, Italy...
7 CitationsSource
#1Lauren Badalato (Katholieke Universiteit Leuven)H-Index: 1
#2Louiza Kalokairinou (Katholieke Universiteit Leuven)H-Index: 6
Last.Pascal Borry (Katholieke Universiteit Leuven)H-Index: 34
view all 3 authors...
In the wake of recent regulations targeting direct-to-consumer genetic testing (DTC-GT), an increasing number of websites have emerged that offer consumers alternative means to derive health information from their DTC-GT raw data. While the ethical concerns associated with DTC-GT have been extensively discussed in the literature, the implications of third party interpretation (TPI) websites have remained largely unexplored. Here we sought to describe these services and elucidate their ethical im...
19 CitationsSource
#1Louiza Kalokairinou (Katholieke Universiteit Leuven)H-Index: 6
#2Pascal Borry (Katholieke Universiteit Leuven)H-Index: 34
Last.Heidi Carmen Howard (Uppsala University)H-Index: 23
view all 3 authors...
Direct-to-consumer (DTC) genetic tests (GT) have provoked criticism over their potential adverse impact on public health. The European Parliament called for a ban on DTC advertising of GT during the debate for the adoption of a European Regulation on in vitro diagnostic medical devices. This proposal, however, was not ultimately retained in the final text. Instead, the regulation includes an article prohibiting misleading claims for this kind of advertising. These two different approaches raise ...
7 CitationsSource
#1Emilia Niemiec (UNIBO: University of Bologna)H-Index: 4
#2Louiza Kalokairinou (New York City Law Department)H-Index: 6
Last.Heidi Carmen Howard (Uppsala University)H-Index: 23
view all 3 authors...
2 CitationsSource
#2Heidi HowardH-Index: 2
Last.Pascal BorryH-Index: 34
view all 3 authors...
#2Pascal BorryH-Index: 34
Last.Heidi HowardH-Index: 2
view all 3 authors...
#2Heidi HowardH-Index: 2
Last.Pascal BorryH-Index: 34
view all 3 authors...
#1Louiza Kalokairinou (Katholieke Universiteit Leuven)H-Index: 6
#2Heidi Carmen Howard (Uppsala University)H-Index: 23
Last.Pascal Borry (Katholieke Universiteit Leuven)H-Index: 34
view all 3 authors...
Over the past years, direct-to-consumer (DTC) genetic testing has provoked controversy regarding its still questionable risks and benefits. The safety and performance of such devices, when entering the European market, are currently regulated by the Directive 98/79 EC of the European Parliament and of the Council on in vitro diagnostic medical devices. In September 2012, a new Regulation was proposed to replace this Directive, and the legislative process is still ongoing. This article presents t...
6 CitationsSource
#1Sandra JanssensH-Index: 21
Last.Pascal BorryH-Index: 34
view all 8 authors...
Background: An increasing number of direct-to-consumer (DTC) genetic testing companies have started offering tests for carrier status of autosomal recessive disorders. Materials & Methods: A written questionnaire was administered to 47 patients and 65 parents of children with Cystic Fibrosis (CF), a common severe autosomal recessive disorder, to assess their views about the offer of DTC carrier tests. All participants were recruited from a CF patient registry in Belgium. Results & Conclusion: We...
3 CitationsSource
12